Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists’ expertise
Journal Title: Annals of Hepatology - Year 2015, Vol 14, Issue 5
Abstract
Background and aims. The prediction of intermediate stage of fibrosis in chronic hepatitis C represents a prognostic factor for disease progression. Studies evaluating biopsy performance in intermediate stage considering current patterns of liver samples and pathologists’ variability are scarce. We aimed to evaluate the effect of optimal liver specimens (≥ 20 mm and/or ≥ 11 portal tracts) and pathologists’ expertise on agreement for intermediate stage of fibrosis in chronic hepatitis C. Material and methods. Guided biopsies with large TruCut needle were initially scored by four pathologists with different expertise in liver disease and posteriorly reviewed by a reference hepatopathologist to evaluate fibrosis agreement. Results. Of the 255 biopsies initially selected, 240 met the criteria of an optimal fragment (mean length 24 ± 5 mm; 16 ± 6 portal tracts) and were considered for analysis. The overall agreement among all fibrosis stages was 77% (κ = 0.66); intraobserver and interobserver agreement was, respectively, 97% (k = 0.96) and 73% (κ = 0.60). Excluded samples (< 20 mm and < 11 portal tracts) presented a lower agreement (40%; κ = 0.24). Stratifying fibrosis stages, an interobserver agreement of 42% was found in intermediate stage (F2), ranging from 0 to 56% according to pathologists’ expertise, compared to 97% in mild (F0-F1) and 72% in advanced fibrosis (≥ F3) (p < 0.001). Of the 23% misclassified cases, fibrosis understaging occurred in 82% of specimens, predominantly in F2, even when evaluated by a hepatopathologist. Conclusions. Liver biopsy presents intrinsic limitations to assess intermediate stage of fibrosis not overcome by optimal samples and experienced pathologists’ analysis, and should not be considered the gold standard method to evaluate intermediate fibrosis in chronic hepatitis C.
Authors and Affiliations
Maria C. Chindamo, Vera L. Nunes-Pannain, João M. Araújo-Neto, Henrique S. Moraes-Coelho, Ronir R. Luiz, Cristiane A. Villela-Nogueira, Renata M. Perez
Keywords
Related Articles
- EP ID EP78490
- DOI -
- Views 115
- Downloads 0
Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis
Background. Sarcopenia is a complication and independent risk factor for mortality in patients with liver cirrhosis. Aim. To assessthe prevalence and influence of sarcopenia on overall survival in a cohort of cirrhotic...
Neuroendocrine metastatic tumors of the liver resembling hepatocellular carcinoma
Certain neuroendocrine tumors (NET) metastasized to the liver can resemble hepatocellular carcinoma (HCC) in cytological needle biopsy. Experience concerning the histologic characteristics of metastatic NET resembling HC...
Risk and Prognosis of Acute Liver Injury Among Hospitalized Patients with Hemodynamic Instability: A Nationwide Analysis
Risk and Prognosis of Acute Liver Injury Among Hospitalized Patients with Hemodynamic Instability: A Nationwide Analysis Introduction and aim. Critically ill patients in states of circulatory failure are at risk of acute...
Surgical morbidity in severely obese liver transplant recipients - A single Canadian Centre Experience
The prevalence of obesity is increasing globally, with nearly half of a billion of the world’s population now considered to be overweight or obese. Obesity and overweight patients are one of the major health issues in Ca...
Right hepatic artery aneurysms in a child with Kawasaki disease: flow-preserving endovascular treatment